BioAge Labs (BIOA) Revenue (2025 - 2026)
BioAge Labs' (BIOA) quarterly Revenue came in at $2.8 million in Q1 2026, up 91.04% year-on-year from $1.5 million in Q1 2025, and down 9.94% quarter-over-quarter from $3.1 million in Q4 2025.
BioAge Labs (BIOA) Revenue (2025 - 2026) Analysis & Trends
BioAge Labs has disclosed Revenue across 2 years of filings, most recently posting $2.8 million for Q1 2026.
- Revenue for Q1 2026 came in at $2.8 million, up 91.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.3 million (up 610.96% YoY), and the FY2025 annual result was $9.0 million, changed N/A from the prior year.
- Revenue came in at $2.8 million for Q1 2026 at BioAge Labs, down from $3.1 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $3.1 million in Q4 2025 to a low of $1.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | BioAge Labs | 659.72 Mn | 276.53 Mn | -10.37 Mn | 2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 1.45 Mn |